Attached files
| file | filename |
|---|---|
| EX-31.1 - EX-31.1 - Kaleido Biosciences, Inc. | kldo-ex311_231.htm |
| EX-21.1 - EX-21.1 - Kaleido Biosciences, Inc. | kldo-ex211_315.htm |
| 10-K - 10-K - Kaleido Biosciences, Inc. | kldo-10k_20191231.htm |
| EX-32.2 - EX-32.2 - Kaleido Biosciences, Inc. | kldo-ex322_229.htm |
| EX-32.1 - EX-32.1 - Kaleido Biosciences, Inc. | kldo-ex321_230.htm |
| EX-31.2 - EX-31.2 - Kaleido Biosciences, Inc. | kldo-ex312_232.htm |
| EX-10.13 - EX-10.13 - Kaleido Biosciences, Inc. | kldo-ex1013_345.htm |
| EX-4.3 - EX-4.3 - Kaleido Biosciences, Inc. | kldo-ex43_314.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in this Registration Statement No. 333-230167 on Form S-8 of our report dated March 2, 2020 relating to the financial statements of Kaleido Biosciences, Inc., appearing in this Annual Report on Form 10-K for the year ended December 31, 2019.
/s/ Deloitte & Touche LLP
Boston, Massachusetts
March 2, 2020